Diazepane-acetamide derivatives as selective 11.beta.-hsd1...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 243/08 (2006.01) A61K 31/551 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2668504

The present invention relates to diazepane-acetamide derivatives of formula I as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11 .beta.-HSD-1 ) and the use of such compounds for the treatment and prevention of metabolic syndrome, diabetes, insulin resistance, obesity, lipid disorders, glaucoma, osteoporosis, cognitive disorders, anxiety, depression, immune disorders, hypertension and other diseases and conditions.

La présente invention concerne des dérivés de diazépane-acétamide de formule I en tant qu'inhibiteurs sélectifs de l'enzyme 11-bêta-hydroxystéroïde déshydrogénase de type 1 (11 .beta.-HSD-1) et l'utilisation de tels composés pour le traitement et la prévention du syndrome métabolique, du diabète, de la résistance à l'insuline, de l'obésité, des troubles lipidiques, du glaucome, de l'ostéoporose, des troubles cognitifs, de l'anxiété, de la dépression, des troubles immunitaires, de l'hypertension et d'autres maladies et troubles.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diazepane-acetamide derivatives as selective 11.beta.-hsd1... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diazepane-acetamide derivatives as selective 11.beta.-hsd1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazepane-acetamide derivatives as selective 11.beta.-hsd1... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1806971

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.